Although increased serum DKK1 seemed to be an early event in prostate cancer, which declines as cancer progresses, high DKK1 levels were associated with shorter overall survival suggesting that DKK1 could serve as a cancer prognostic marker [50]. This evidence concerns the gene DKK1 and prostate carcinoma.